Table 2.
Clinical parameters | Control group (mean ± SD) |
Median | 95% CI | Test group (mean ± SD) |
Median | 95% CI | p |
---|---|---|---|---|---|---|---|
Modified plaque index | |||||||
Patient-level | 0.46 ± 0.43 | 0.33 | 0.38–0.54 | 0.49 ± 0.42 | 0.50 | 0.41–0.57 | 0.56 |
Implant-level | 0.49 ± 0.41 | 0.33 | 0.44–0.54 | 0.51 ± 0.43 | 0.50 | 0.46–0.56 | 0.51 |
Bleeding on probing (%) | |||||||
Patient-level | 33.07 ± 30.37 | 33 | 27.36–38.79 | 32.26 ± 30.88 | 17 | 26.71–37.82 | 0.084 |
Implant-level | 36.77 ± 32.23 | 33 | 33–40.10 | 35.53 ± 32.67 | 33 | 31.76–39.30 | 0.648 |
Probing depth (mm) | |||||||
Patient-level | 3.0 ± 0.72 | 2.83 | 2.86-3.13 | 2.86 ± 0.96 | 2.67 | 2.68-3.03 | 0.22 |
Implant-level | 3.0 ± 0.85 | 2.83 | 2.90–3.11 | 2.78 ± 0.86 | 2.67 | 2.68–2.88 | 0.002 |
Mucosal recession (mm) | |||||||
Patient-level | 0.17 ± 0.34 | 0 | 0.10–0.23 | 0.18 ± 0.36 | 0 | 0.11–0.24 | 0.79 |
Implant-level | 0.16 ± 0.36 | 0 | 0.12–0.20 | 0.19 ± 0.36 | 0 | 0.16–0.24 | 0.221 |